Multiple Antioxidants and L-Arginine Modulate Inflammation and Dyslipidemia in Chronic Renal Failure Rats

REFERENCES

• Ignarro LJ, Wei L. Visiting professorial lecture: Nitric oxide in the regulation of vascular function: A historical overview. J Card Surg. 2002;17(4):301–306.
   PubMedGoogle Scholar
• Gornik HL, Creager MA. Arginine and endothelial and vascular health. J Nutr. 2004;134 (Suppl. 10):2880S–2887S.
   Google Scholar
• Levillain O, Marescau B, de Deyn PP. Guanidino compound metabolism in rats subjected to 20% to 90% nephrectomy. Kidney Int. 1995 Feb;47(2):464–472.
   PubMedGoogle Scholar
• Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM. Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol. 1981;241:F85–F93.
   PubMed Web of Science ®Google Scholar
• Matasumuto M, Kishikawa H, Mori A. Guanidino compounds in the sera of uremic patients and in the sera of and brain of experimental rabbits. Biochem Med. 1978;6:161–168.
   Google Scholar
• Mendoza MG, Castillo-Henkel C, Medina-Santillan R, Kidney damage after renal ablation is worsened in endothelial nitric oxide synthase -/- mice and improved by combined administration of L-arginine and antioxidants. Nephrology (Carlton). 2008 Jun;13(3):218–227.
   PubMedGoogle Scholar
• Baylis C. Nitric oxide deficiency in chronic kidney disease. Am J Physiol. 2008;294:F1–F9.
   PubMed Web of Science ®Google Scholar
• Bonomini M, Sirolli V, Di Pietro N, Pandolfi A. Reduced nitric oxide bioavailability in chronic renal failure: A new factor of progression? G Ital Nefrol. 2008;25(3):306–316.
   PubMedGoogle Scholar
• Benchetrit S. Early endothelial dysfunction following renal mass reduction in rats. Eur J Clinc Invest. 2003;33(1):26–33.
   PubMedGoogle Scholar
• Aiello S, Noris M, Remuzzi G. Nitric oxide synthesis and L-arginine in uremia. Miner Electrolyte Metab. 1997;23(3–6):151–156.
   PubMedGoogle Scholar
• Nathan C, Xie QW. Regulation of biosynthesis of nitricoxide. J Biol Chem. 1994;269(19):13725–13728.
   PubMed Web of Science ®Google Scholar
• Taylor BS, Geller DA. Molecular regulation of the human inducible nitric oxide synthase (iNOS) gene. Shock. 2000;13(6):413–424.
   PubMedGoogle Scholar
• Rawlingson A, Greenacre SA, Brain SD. Functional significance of iNOS induction, neutrophil accumulation and protein nitration in the thermally injured rat cutaneous microvasculature. Am J Pathol. 2003;162(4):1373–1380.
   PubMedGoogle Scholar
• Lortie MJ, Ishizuka S, Schwartz D, Blantz RC. Bioactive products of arginine in sepsis: Tissue and plasma composition after LPS and iNOS blockade. Am J Physiol Cell Physiol. 2000;278:C1191–C1199.
   Google Scholar
• Yamamizu K, Shinozaki K, Ayajiki K, Gemba M, Okamura T. Oral administration of both tetrahydrobiopterin and L-arginine prevents endothelial dysfunction in rats with chronic renal failure. J Cardiovasc Pharmacol. 2007;49(3):131–139.
   PubMedGoogle Scholar
• Nieves C Jr, Langkamp-Henken B. Arginine and immunity: A unique perspective. Biomed Pharmacother. 2002;56:471–482.
   PubMed Web of Science ®Google Scholar
• Barbul A, Lazarou SA, Efron DT, Wasserkrug HL, Efron G. Arginine enhances wound healing and lymphocyte immune responses in humans. Surgery. 1990;108:331–336.
   PubMed Web of Science ®Google Scholar
• Cui XL, Iwasa M, Iwasa Y, Ogoshi S. Arginine-supplemented diet decreases expression of inflammatory cytokines and improves survival in burned rats. J Parenter Enteral Nutr. 2000;24:89–96.
   PubMed Web of Science ®Google Scholar
• Canaud B, Cristol JP, Morena M, Leray-Moragues H. Imbalance of oxidants and antioxidants in hemodialysis patients. Blood Purif. 1999;17:99–106.
   PubMed Web of Science ®Google Scholar
• Witko-Sarsat V, Friedlander M, Capeillere-Blandin C. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996;49:1304–1313.
   PubMed Web of Science ®Google Scholar
• Himmelfarb J, Stenvinkel P, Ikizler TA. The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002;62:1524–1538.
   PubMed Web of Science ®Google Scholar
• Descamps-Latscha B, Drueke T, Witko-Sarsat V. Dialysis-induced oxidative stress: Biological aspects, clinical consequences, and therapy. Semin Dial. 2001;14:193–199.
   PubMed Web of Science ®Google Scholar
• Bellinghieri G, Santoro D, Calvani M, Mallamace A, Savica V. Carnitine and hemodialysis. Am J Kidney Dis. 2003;41 (Suppl. 1):S116–S122.
   Google Scholar
• Gloper TA, Wolfson M, Ahmed S. Multicenter trial of L-carnitine in maintenance hemodialysis patients, 1: Carnitine concentration and lipid effects. Kidney Int. 1990;38:904–911.
   PubMedGoogle Scholar
• Guarnieri G, Situlin R, Biolo G. Carnitine metabolism in uremia. Am J Kidney Dis. 2001;38:S63–S67.
   Web of Science ®Google Scholar
• Guarnieri G, Biolo G, Vinci P, Massolino B, Barazzoni R. Advances in carnitine in chronic uremia. J Ren Nutr. 2007 Jan;17(1):23–29.
   PubMedGoogle Scholar
• Matera M, Bellinghieri G, Costantino G, Santoro D, Calvani M, Savica V. History of L-carnitine: Implications for renal disease. J Ren Nutr. 2003 Jan;13(1):2–14.
   PubMedGoogle Scholar
• Lambert JD, Sang S, Yang CS. Biotransformation of green tea polyphenols and the biological activities of those metabolites. Mol Pharm. 2007 Nov–Dec;4(6):819–825.
   PubMed Web of Science ®Google Scholar
• Higdon JV, Frei B. Tea catechins and polyphenols: Health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr. 2003;43:89–143.
   PubMed Web of Science ®Google Scholar
• Yang CS, Hong J, Hou Z, Sang S. Green tea polyphenols: Antioxidative and prooxidative effects. J Nutr. 2004;134:3181S.
   PubMed Web of Science ®Google Scholar
• Oslen JL. Role of heparin as a protective agent following reduction of renal mass. Kidney Int. 1993;44:445–450.
   PubMedGoogle Scholar
• Dumont Y, D'Amours M, Lebel M, Lariviere R. Supplementation with a low dose of L-arginine reduces blood pressure and endothelin, 1: Production in hypertensive uraemic rats. Nephrol Dial Transplant. 2001;16:746–754.
   PubMed Web of Science ®Google Scholar
• Choi JH, Rhee SJ. Effect of Vit E on renal dysfunction in chronic cadmium poisoned rats. J Med Food. 2003;6(3):209–215.
   PubMedGoogle Scholar
• Yargicoglu P, Yaras N, Agar A. The effect of vitamin E on stress-induced changes in visual evoked potentials (VEP) in rats exposed to different experimental stress models. Acta Ophthalmol. Scand. 2003;81(2):181–187.
   PubMedGoogle Scholar
• Mahfouz MM, Kummerow FA. Vitamin C or vitamin B6 supplementation prevents the oxidative stress and decrease of prostacyclin generation in homocysteinemic rats. Int J Biochem Cell Biol. 2004;36(10):1919–1932.
   PubMedGoogle Scholar
• Anjaneyulu M, Tirkey N, Chopra K. Attenuation of cyclosporine-induced renal dysfunction by catechin: Possible antioxidant mechanism. Ren Fail. 2003;25(5):691–707.
   PubMed Web of Science ®Google Scholar
• Sener G, Paskalogu H, Alican I. L-carnitine ameliorates oxidative damage due to chronic renal failure in rats. J Cardiovasc Pharmacol. 2004 May;43(5):698–705.
   PubMed Web of Science ®Google Scholar
• Green LC, Wanger DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate and nitrite and (15N) nitrate in biological fluids. Anal Biochem. 1982;126:131–138.
   PubMed Web of Science ®Google Scholar
• Kaplan A. Urea. In Kaplan A, Pesce J ( eds.). Clinical chemistry: Theory, analysis, and correlation. 1st ed. 1984;1257–1260, 437, 418.
   Google Scholar
• Murray RL. Creatinine. In Kaplan A, ( eds.). Clinical chemistry. St. Louis, Toronto, Princeton: The C. V. Mosby Co.; 1984:1261–1266, 418.
   Google Scholar
• Orsonneau JL, Douet P, Massoubre C, Lustenberger P, Bernard S. An improved pyrogallol red-molybdate method for determining total urinary protein. Clin Chem. 1989;35:2233–2236.
   PubMed Web of Science ®Google Scholar
• Naito HK. Cholesterol. In Kaplan A, ( eds.). Clinical chemistry. St. Louis, Toronto, Princeton: The C. V. Mosby Co.; 1984:1149–1206, 437.
   Google Scholar
• Buccolo G, David H. Quantitative determination of serum triglycerides by use of enzymes. Clin Chem. 1973;19(5):476–482.
   PubMedGoogle Scholar
• Bezerra DG, Pires KMP, Lacerda MD. Amlodipine preserves the glomerular number in spontaneously hypertensive rats. J Cell Mol Med. 2005;9(4):966–971.
   PubMedGoogle Scholar
• Chmielewski M, Carrero JJ, Stenvinkel P, Lindholm B. Metabolic abnormalities in chronic kidney disease that contribute to cardiovascular disease, and nutritional initiatives that may diminish the risk. Curr Opin Lipidol. 2009 Feb;20(1):3–9.
   PubMedGoogle Scholar
• Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999;55:648–658.
   PubMed Web of Science ®Google Scholar
• Bevc S, Sabic S, Hojs R. Atherosclerosis in hemodialysis patients—the role of microinflammation. Ren Fail. 2008;30(10):1012–1016.
   PubMed Web of Science ®Google Scholar
• Korish AA, Arafah MM. Catechin combined with vitamins C and E ameliorates insulin resistance (IR) and atherosclerotic changes in aged rats with chronic renal failure (CRF). Archives of Gerontology and Geriatrics. 2008;46:25–39.
   PubMedGoogle Scholar
• Massy ZA, Nguyen-Khoa T. Oxidative stress and chronic renal failure: Markers and management. J Nephrol. 2002;15:336–341.
   PubMed Web of Science ®Google Scholar
• Göçmen AY, Sahin E, Koçak H, Tuncer M, Gümüşlü S. Levels of asymmetric dimethylarginine, nitric oxide and lipid peroxidation markers in patients with end-stage renal disease having peritoneal dialysis treatment. Clin Biochem. 2008 Jul;41(10–11):836–840.
   PubMedGoogle Scholar
• Huang PL, Huang Z, Mashimo H. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 1995;377:239–242.
   PubMed Web of Science ®Google Scholar
• Siani A, Pagana E, Lacone R, Lacoviello L. Blood pressure and metabolic changes during dietary L-arginine supplementation in humans. Am J Hypertens. 2000;13:547–551.
   PubMed Web of Science ®Google Scholar
• El-Mesallamy HO, Abdel Hamid SG, Gad MZ. Oxidative stress and asymmetric dimethylarginine are associated with cardiovascular complications in hemodialysis patients: Improvements by L-arginine intake. Kidney Blood Press Res. 2008;31(3):189–195.
   PubMedGoogle Scholar
• Boger RH. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the “L-arginine paradox” and acts as a novel cardiovascular risk factor. J Nutr. 2004;134(Suppl. 10):2842S–2847S.
   Google Scholar
• Cherla G, Edgar A, Jaimes EA. Role of L-arginine in the pathogenesis and treatment of renal disease. J Nutr. 2004;134(Suppl. 10):2801S–2806S.
   Google Scholar
• Rossi NF, Beierwaltes WH. Nitric oxide modulation of ETB receptor induced vasopression release by rat and mouse hypothalamo-neurohypophyseal explants. Am J Physiol Regul Integr Comp. 2006;290:R1208–R1215.
   Google Scholar
• Nabokov A, Amann K, Wagner J, Gehlen F, Munter K, Ritz E. Influence of specific and non-specific endothelin receptor antagonists on renal morphology in rats with surgical renal ablation. Nephrol Dial Transplant. 1996;11:514–520.
   PubMed Web of Science ®Google Scholar
• Peters H, Border WA, Noble NA. Tandem antifibrotic action of L-arginine supplementation and low protein diet during the repair phase of experimental glomerulonephritis. Kidney Int. 2000;57:992–1001.
   PubMed Web of Science ®Google Scholar
• Sydow K, Schwedhelm E, Arakawa N. ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inenia: Effects of L-arginine and B vitamins. Cardiovascular Research. 2003;57:244–252.
   PubMed Web of Science ®Google Scholar
• Maines MD. The heme oxygenase system: A regulator of second messenger gases. Ann Rev Pharmacol Toxicol. 1997;37:517–554.
   PubMed Web of Science ®Google Scholar
• Calo LA, Pagnin E, Davis P. Antioxidant effect of L-carnitine and its short chain esters relevance for the protection from oxidative stress related cardiovascular damage. Int J Cardiol. 2006;107(1):54–60.
   PubMed Web of Science ®Google Scholar
• Korish AA, Arafah MM. The potential anti-inflammatory effect of tetrahydrobiopetrin administration in renal mass reduction-induced chronic renal failure in rats. Saudi Medical Journal. 2007;28(12):1803–1809.
   PubMedGoogle Scholar
• Stonvinkel P, Lindholm B, Heimburger M, Heimburger O. Elevated serum levels of soluble adhesion molecules predicted death in predialysis patients: Association with malnutrition, inflammation and, cardiovascular disease. Nephrol Dial Transplant. 2000;15:1624–1630.
   PubMedGoogle Scholar
• Bonomini M, Reale M, Santarelli P, Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients. Nephron. 1998;79:339–407.
   Google Scholar
• Ridker PM, Hemekens CH, Roitman-Johnson B, Stapfer MJ, Allen J. Plasma concentrations of soluble intercellular adhesion molecule 1 and risk of future myocardial infarction in apparently healthy men. Lancet. 1998;351:88–92.
   PubMed Web of Science ®Google Scholar
• Papayianni A, Alexopoulos E, Giamalis P, Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in hemodialysis patients: Association within inflammation, dyslipidaemia, and vascular events. Nephrol Dial Transplant. 2002;17:435–441.
   PubMed Web of Science ®Google Scholar
• Brunini T, Ribeiro AC, Ellory JC, Mann GE. Platelet nitric oxide synthesis in uremia and malnutrition: A role for L-arginine supplementation in vascularprotection? Cardiovascular Research. 2007;73:359–367.
   PubMed Web of Science ®Google Scholar
• Abdullah MS, Wild G, Jacob V, Milford-Ward A, Ryad R, Zanaty M. Cytokines and the malnutrition of chronic renal failure. Miner Electrolyte Metab. 1997;23:237–242.
   PubMedGoogle Scholar
• Kubes P, Kusose I, Granger DN. NO donors prevent intregin induced leukocyte adhesion, but not P-selectin-dependent rolling in post ischemic venules. Am J Physiol. 1994;267:H931–H937.
   PubMed Web of Science ®Google Scholar
• Lindemann S, Sharaf M, Spiecker M, Buerke M, Fisch A, Grosser T. NO reduces PMN adhesion to human vascular endothelial cells due to downregulation of ICAM-1mRNA and surface expression. Thromb Res. 2000;97(3):113–123.
   PubMedGoogle Scholar
• Kubes P, Suzuki M, Granger DN. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA. 1991;88(11):4651–4655.
   PubMed Web of Science ®Google Scholar
• Lefer DJ, Jones SP, Girod WG, Leukocyte-endothelial cell interactions in nitric oxide synthase deficient mice. Am J Physiol. 1999;276(6Pt2):H1943–H1950.
   Google Scholar
• Kosonen O, Kankaanranta H, Uotila J, Moilanen E. Inhibition by nitric oxide-releasing compounds of E-selectin expression in and neutrophil adhesion to human endothelial cells. Eur J Pharmacol. 2000;394(1):149–156.
   PubMedGoogle Scholar
• Maccarrone M, Meloni C, Manca-di-Villahermosa S, Vitamin E suppressed 5-lipoxygenase-mediated oxidative stress in peripheral blood mononuclear cells of hemodialysis patients regardless of administration route. Am J Kidney Dis. 2001;37:964–969.
   PubMed Web of Science ®Google Scholar
• Meagher EA, Barry OP, Lawson JA, Rokach J, Fitzgerald GA. Effects of vitamin E on lipid peroxidaton in healthy persons. JAMA. 2001;285:1178–1182.
   PubMed Web of Science ®Google Scholar
• Costagliola C, Menzione M. Effect of vitamin E on the oxidative state of glutathione in plasma. Clin Physiol Biochem. 1990;8:140–143.
   PubMedGoogle Scholar
• Arduini A, Rossi M, Mancinelli G. Effect of L-carnitine and acetyl-L-carnitine on the human erythrocyte membrane stability and deformability. Life Sci. 1990;47:2395–2400.
   PubMed Web of Science ®Google Scholar
• Packer L, Valenza M, Serbinova E. Free radical scavenging is involved in the protective effect of L-propionyl-carnitine against ischemia-reperfusion injury of the heart. Arch Biochem Biophys. 1991;288:533–537.
   PubMed Web of Science ®Google Scholar
• Libera L, Sabbadini R, Renken C. Apoptosis in the skeletal muscle of rats with heart failure is associated with increased serum levels of TNF and sphingosine. J Moll Cell Cardiol. 2001;33:1871–1878.
   PubMedGoogle Scholar
• Rodriguez-Segade S, del la Pena C, Paz M. Carnitine concentration in dialysed and undialysed patients with chronic renal insufficiency. Ann Clin Biochem. 1986;23:671–675.
   PubMedGoogle Scholar
• El-Metwally TH, Hamed EA, Ahmad AR, Mohamed NA. Dyslipidemia, oxidative stress and cardiac dysfunction in children with chronic renal failure: Effects of L-carnitine supplementation. Ann Saudi Med. 2003 Sep–Oct;23(5):270–277.
   PubMedGoogle Scholar
• Vescovo G, Zennaro R, Sandri M. Apoptosis of skeletal muscle myofibrils and interstitial cells in experimental heart failure. J Mol Cell Cardiol. 1998;30:2449–2459.
   PubMed Web of Science ®Google Scholar
• Savica V, Santo D, Ciolino F. L-carnitine infusions may suppress serum C-reactive protein and improve nutritional status in maintenance hemodialysis patients. J Renal Nutr. 2005;15(2):225–230.
   PubMedGoogle Scholar
• Chander V, Singh D, Chopra K. Catechin, a natural antioxidant protects against rhabdomyolysis-induced myoglobinuric acute renal failure. Pharmacological Research. 2003;48:503–509.
   PubMed Web of Science ®Google Scholar
• Jolma P, Koobi P, Kalliovalkama J. Increased calcium intake reduces plasma cholesterol and improves vasorelaxation in experimental renal failure. Am J Physiol Heart Circ Physiol. 2003;285:H1882–H1889.
   Web of Science ®Google Scholar
• Altaf A, Halim A, Khan DA, Khalid M, Fatima-Tuz-Zuhra SI. Assessment of lipid dysfunction in patients on maintenance hemodialysis. J Ayub Med Coll Abbottabad. 2007 Oct–Dec;19(4):32–36.
   PubMedGoogle Scholar
• Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ. Impaired vasodilatation of forearm resistance vessels in hypercholestrolemic humans. J Clin Invest. 1990;86:228–234.
   PubMed Web of Science ®Google Scholar
• Mougenot N, Lesnik P, Ramirez-Gil JF, Effect of oxidation of LDL on the modulation of arterial vasomotor response in vitro. Atherosclerosis. 1997;133:183–192.
   PubMed Web of Science ®Google Scholar
• Vaziri ND, Deng G, Liang K. Hepatic HDL receptor, SR-B1 and Apo A-I expression in chronic renal failure. Nephrol Dial Transplant. 1999 Jun;14(6):1462–1466.
   PubMedGoogle Scholar
• Hasselwander O, McEneny J, McMaster D, HDL composition and HDL antioxidant capacity in patients on regular hemodialysis. Atherosclerosis. 1999 Mar;143(1):125–133.
   PubMedGoogle Scholar
• Kaysen GA, Eiserich JP. The role of oxidative stress-altered lipoprotein structure and function and microinflamation on cardiovascular risk in patients with minor renal dysfunction. J Am Soc Nephrol. 2004;15(3):538–548.
   PubMedGoogle Scholar
• Attman PO, Gustafon A. Abnormalities of lipid metabolism. In Giovannetti S ( ed.). Nutritional treatment of chronic renal failure. Boston, Mass.: Kluwer Academic Publishers; 1989:294–295.
   Google Scholar
• Sokolovic D, Bjelakovic G, Nikolic J, Effect of L-arginine on metabolism of polyamines in rat's brain with extrahepatic cholestasis. Amino Acids. 2009 Mar 13. [Epub ahead of print]
   PubMedGoogle Scholar
• Shimizu M, Shirakami Y, Sakai H, (-)-Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL/KsJ-db/db mice. Cancer Prev Res (Phila Pa). 2008 Sep;1(4):298–304.
   PubMed Web of Science ®Google Scholar
• Lee SM, Kim CW, Kim JK, Shin HJ, Baik JH. GCG-rich tea catechins are effective in lowering cholesterol and triglyceride concentrations in hyperlipidemic rats. Lipids. 2008 May;43(5):419–429.
   PubMed Web of Science ®Google Scholar
• Ramesh E, Elanchezhian R, Sakthivel M, Epigallocatechin gallate improves serum lipid profile and erythrocyte and cardiac tissue antioxidant parameters in Wistar rats fed an atherogenic diet. Fundam Clin Pharmacol. 2008 Jun;22(3):275–284.
   PubMed Web of Science ®Google Scholar
• Malaguarnera M, Vacante M, Avitabile T, Malaguarnera M, Cammalleri L, Motta M. L-carnitine supplementation reduces oxidized LDL cholesterol in patients with diabetes. Am J Clin Nutr. 2009;89(1):71–76.
   PubMed Web of Science ®Google Scholar
• Solfrizzi V, Capurso C, Colacicco AM, Efficacy and tolerability of combined treatment with L-carnitine and simvastatin in lowering lipoprotein(a) serum levels in patients with type 2 diabetes mellitus. Atherosclerosis. 2006 Oct;188(2):455–461.
   PubMedGoogle Scholar
• Tribe RM, Poston L. Oxidative stress and lipids in diabetes: A role in endothelium vasodilator dysfunction. Vas Med. 1996;1:195–206.
   PubMedGoogle Scholar
• Siani A, Pagano E, Lacone R, Lacoviello L. Blood pressure and metabolic changes during dietary L-arginine supplementation in humans. Am J Hypertens. 2000;13:547–551.
   PubMed Web of Science ®Google Scholar
• Heyland DK, Novak F, Drover JW, Jain M, Su X, Suchner U. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA. 2001;286:944–953.
   PubMed Web of Science ®Google Scholar